3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Dermatologic
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Gastrointestinal Stromal Tumors
71
Neoplasm Metastasis
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Stomach Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neoplasms
3
Digestive System Neoplasms
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Piebaldism
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Hodgkin Disease
2
Gastrointestinal Neoplasms
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Thrombocytosis
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Interventions
pembrolizumab
3
Nivolumab
2
tislelizumab
1
Trastuzumab
1
Tablets
1
Specimen Handling
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunotherapy
1
Imatinib Mesylate
1
Drug Therapy
1
Docetaxel
1
Cyclophosphamide
1
Combined Modality Therapy
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Imatinib Mesylate
×
Gastrointestinal
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled